Alpine Woods Capital Investors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
Alpine Woods Capital Investors's RGEN Position: Q2 2026 in Review
Alpine Woods Capital Investors reduced its Repligen (RGEN) stake by 5.7% in Q2 2026, selling an estimated $16.2K and leaving 2,165 shares worth $295K. The position accounts for 0.06% of the portfolio, ranked #163.
Alpine Woods Capital Investors first reported a position in RGEN in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.01M in Q4 2025. 477 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Alpine Woods Capital Investors held 2,165 shares of Repligen worth $295K as of Q2 2026.
- Alpine Woods Capital Investors sold 132 Repligen shares in Q2 2026, an estimated $16.2K.
- Repligen made up 0.06% of Alpine Woods Capital Investors's portfolio in Q2 2026, its #163 holding.
- Alpine Woods Capital Investors first reported a position in Repligen in Q4 2025 and has held it in 3 quarters since.
- Alpine Woods Capital Investors's Repligen position peaked at $1.01M in Q4 2025.
- 477 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Alpine Woods Capital Investors's 13F filing for Q2 2026, filed 7 Aug 2026.